Eurofins-Cerep SA (EPA: ALECR)
France
· Delayed Price · Currency is EUR
19,600
0.00 (0.00%)
Jan 7, 2025, 5:24 PM CET
Eurofins-Cerep Company Description
Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally.
The company’s research services include compound management, and high-throughput screening and profiling.
The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and is based in Celle-Lévescault, France.
Eurofins-Cerep SA is a subsidiary of Eurofins Discovery Services LUX Holding SARL.
Eurofins-Cerep SA
Country | France |
Founded | 1989 |
Industry | Diagnostics & Research |
Sector | Healthcare |
Employees | 228 |
CEO | Damien Vielliard |
Contact Details
Address: 2 rue du professeur Gargouïl Celle-Lévescault, Ile-de-France 86600 France | |
Phone | 33 5 49 89 30 00 |
Website | eurofins.fr |
Stock Details
Ticker Symbol | ALECR |
Exchange | Euronext Paris |
Fiscal Year | January - December |
Reporting Currency | EUR |
ISIN Number | FR0013256518 |
SIC Code | 8731 |
Key Executives
Name | Position |
---|---|
Antoine Duthilleul | MD, Director and President of The Eurofins Discovery Products France |
Sophie Macault | General Counsel and Corporate Secretary |